MapLight Therapeutics (MPLT) Stock Price & Financial Analysis
MapLight Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About MapLight Therapeutics
What is the current stock price for MPLT?
As of the latest trading session, MPLT stock trades at $21.17. The 52-week range is $12.24–$21.55, with a day range of $20.31–$21.76.
What is the P/E ratio for MPLT?
The P/E ratio (Price-to-Earnings) for MPLT is shown in the Key Statistics section. This valuation metric helps compare MapLight Therapeutics, Inc. to industry peers.
Does MPLT pay dividends?
MapLight Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MPLT?
Based on 1 analyst, the consensus for MPLT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of MPLT?
MapLight Therapeutics's market capitalization is $877.1M, classifying it as a small-cap company. MapLight Therapeutics operates in the Healthcare sector within the Biotechnology industry.